Clinical Trials Browser

INDUSTRY × Interventional × Acetylcarnitine × Clear all

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

NCT01526564 2013-11-11

Clinical Study on Acetyl-L-Carnitine

Phase 3 Completed

Peripheral Sensory Neuropathy